Search the webpage

Marc Cerrada-Gimenez, PhD

Marc Cerrada-Gimenez, PhD

Director In Vivo Pharmacology

Director In Vivo Pharmacology

ABOUT

Dr. Cerrada-Gimenez obtained his PhD in Biotechnology from the A.I. Virtanen Institute at the University of Eastern Finland in 2011. Shortly thereafter, Marc joined Charles River Discovery Services (Kuopio, Finland), where he led the Biomarker and in vitro team designing and leading multiple projects, which aimed at studying various neurodegenerative indications.

In 2016, he joined the biotech Minoryx Therapeutics as Head of Biomarker Discovery collaborating in the development of compounds for the treatment of rare diseases, with the most advanced candidate currently undergoing Phase II-III. During that time he acquired experience in the preparation and submission of regulatory documents for the EMA and FDA.

FOLLOW

LATEST NEWS

Experimentica Ltd. Sponsors the 2018 SILK-Elsemay Björn Symposium

News
Experimentica Ltd. is pleased to announce its co-sponsorship and participation in this year’s SILK - Elsemay Björn Symposium. This yearly ... Read More

Check out our new publication on the mouse dry-eye disease model

An alpha1 adrenergic agonist shows preclinical efficacy in a preclinical model for dry eye syndrome ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!